Influence of terminal residue on adjacent disaccharide immunogenicity

Molecular Immunology
F J IrazoquiG A Nores

Abstract

Aberrant O-glycosylation of cell surface mucin antigens is characteristic of epithelial cancer cells. For example, Thomsen-Friedenreich disaccharide (TFD) is a chemically well-defined carbohydrate antigen with a documented link to malignancy. There have been many attempts to improve immune response to carbohydrate antigens, for use in immunotherapy. As part of an alternative strategy to improve carbohydrate immunogenicity, we studied the influence of terminal benzyl (Bzl) or p-nitrophenyl (pNP) residue on immunogenicity of adjacent TFD. Mice immunized with keyhole limpets hemocyanin-TFD (KLH-TFD), KLH-TFD(alpha)Bzl, or KLH-TFD(alpha)pNP produced anti-KLH antibodies, which were analyzed by enzyme-linked immunosorbent assay (ELISA). KLH-TFD did not give significant anti-TFD antibody titer, confirming the poor immunogenicity of TFD. Immunization with KLH-TFD(alpha)Bzl and KLH-TFD(alpha)pNP raised antibody titers against TFD(alpha)Bzl and TFD(alpha)pNP, respectively. KLH-TFD(alpha)Bzl also gave higher anti-TFD antibody response, whereas KLH-TFD(alpha)pNP did not, indicating that terminal Bzl residue improves immune response to adjacent carbohydrate. Analysis of anti-TFD(alpha)Bzl or anti-TFD(alpha)pNP IgG antibodies by competitive ...Continue Reading

References

Dec 15, 1992·Carbohydrate Research·H OhbayashiA Kobata
May 1, 1990·The Journal of Infectious Diseases·J B Robbins, R Schneerson
Jan 1, 1974·Immunological Communications·K M Wang, M Reichlin
Jun 15, 1984·Science·G F Springer
Feb 1, 1996·Glycoconjugate Journal·E F HounsellD V Renouf
Jul 1, 1997·Scandinavian Journal of Immunology·C M BöhmC Hanski
Aug 1, 1997·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·G F Springer
Oct 23, 1997·Nature·D SamesS J Danishefsky
Jan 13, 1999·Glycobiology·F J IrazoquiG A Nores
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·S F SlovinH I Scher
Oct 13, 1999·FEMS Immunology and Medical Microbiology·M L Kim, J M Slauch
Dec 2, 1999·Biochimica Et Biophysica Acta·I Brockhausen
Mar 4, 2000·International Journal of Cancer. Journal International Du Cancer·G RagupathiP O Livingston

❮ Previous
Next ❯

Citations

Apr 21, 2010·Immunology and Cell Biology·Victor G SendraFernando J Irazoqui
Jul 22, 2005·Immunology and Cell Biology·Fernando J IrazoquiGustavo A Nores
Sep 4, 2009·Molecular Immunology·Victor G SendraFernando J Irazoqui
Aug 27, 2005·Biochemical and Biophysical Research Communications·Fernando J IrazoquiGustavo A Nores

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.